Education
About Us
Working with TipRanks
Follow Us
Carlsmed, Inc. (CARL)
NASDAQ:CARL
CARL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.81 - $16.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)130.93K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Aug 28, 2025EPS Estimate
-0.91Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,581,135
10 Day Avg. Volume98,085
30 Day Avg. Volume130,925
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$18.50Price Target Upside42.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
InnovationCarlsmed’s Aprevo Technology Platform is pioneering a new standard of care in spine fusion surgery with custom 3D printed interbody implants and an AI enabled surgical planning software.
Market OpportunityCARL is capitalizing on a ~$13.4B market opportunity, indicating a significant potential for future expansion and revenue growth.
Revenue GrowthCARL is confident in its full year revenue guide due to strong new surgeon adoption and scheduled procedure volume visibility.
Bears Say
ValuationThe valuation is at the high end of other high growth medtech companies due to CARL’s high revenue growth and high gross margin profile.
Carlsmed, Inc. News
CARL FAQ
What was Carlsmed, Inc.’s price range in the past 12 months?
Carlsmed, Inc. lowest stock price was $11.81 and its highest was $16.20 in the past 12 months.
What is Carlsmed, Inc.’s market cap?
Currently, no data Available
When is Carlsmed, Inc.’s upcoming earnings report date?
Carlsmed, Inc.’s upcoming earnings report date is Aug 28, 2025 which is 39 days ago.
How were Carlsmed, Inc.’s earnings last quarter?
Carlsmed, Inc. released its earnings results on Aug 28, 2025. The company reported -$1.47 earnings per share for the quarter, missing the consensus estimate of -$0.914 by -$0.556.
Is Carlsmed, Inc. overvalued?
According to Wall Street analysts Carlsmed, Inc.’s price is currently Undervalued.
Does Carlsmed, Inc. pay dividends?
Carlsmed, Inc. does not currently pay dividends.
What is Carlsmed, Inc.’s EPS estimate?
Carlsmed, Inc.’s EPS estimate is -0.91.
How many shares outstanding does Carlsmed, Inc. have?
Carlsmed, Inc. has 26,581,135 shares outstanding.
What happened to Carlsmed, Inc.’s price movement after its last earnings report?
Carlsmed, Inc. reported an EPS of -$1.47 in its last earnings report, missing expectations of -$0.914. Following the earnings report the stock price went down -2.849%.
Which hedge fund is a major shareholder of Carlsmed, Inc.?
Currently, no hedge funds are holding shares in CARL
Company Description
Carlsmed, Inc.
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
CARL Earnings Call
Q2 2025
0:00 / 0:00
CARL Stock 12 Month Forecast
Average Price Target
$18.50
▲(42.64% Upside)
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---